KCM
VRCA icon

Kalehua Capital Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Kalehua Capital Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-235,779
Closed -$1.96M – 28
2025
Q4 		$1.96M Buy
+235,779
New +$1.31M 1.94% 14

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kalehua Capital Management's VRCA Position: Q1 2026 in Review

Kalehua Capital Management sold out of Verrica Pharmaceuticals (VRCA) in Q1 2026, closing a stake of 235,779 shares — an estimated $1.96M sold.

Kalehua Capital Management first reported a position in VRCA in Q4 2025 and held it in 1 quarter. The position peaked at $1.96M in Q4 2025. 39 funds tracked by Wall St. Rank hold VRCA as of Q1 2026.

  • Kalehua Capital Management reported no remaining Verrica Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Kalehua Capital Management sold 235,779 Verrica Pharmaceuticals shares in Q1 2026, an estimated $1.96M.
  • Kalehua Capital Management first reported a position in Verrica Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Kalehua Capital Management's Verrica Pharmaceuticals position peaked at $1.96M in Q4 2025.
  • 39 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2026.

Based on Kalehua Capital Management's 13F filing for Q1 2026, filed 15 May 2026.